Tobacco Use Cessation Devices: Clinical Trials

396 trials of Tobacco Use Cessation Devices, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

296 completed, 25 recruiting, 22 unknown, 20 terminated. 140 Not applicable, 92 Phase 4, 76 Phase 2, 42 Phase 3, 39 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable140Completed 99, Unknown 9, Terminated 8, Active not recruiting 7, Recruiting 7, Withdrawn 6, Not yet recruiting 3, Suspended 1
Phase 492Completed 70, Recruiting 7, Terminated 4, Unknown 4, Active not recruiting 3, Not yet recruiting 2, Withdrawn 2
Phase 276Completed 59, Recruiting 7, Terminated 6, Withdrawn 2, Not yet recruiting 1, Unknown 1
Phase 342Completed 30, Recruiting 4, Terminated 3, Unknown 3, Active not recruiting 1, Not yet recruiting 1
Phase 139Completed 36, Unknown 2, Withdrawn 1
Early Phase 117Completed 8, Active not recruiting 2, Recruiting 2, Unknown 2, Withdrawn 2, Terminated 1

Follow this drug Literature Review of Tobacco Use Cessation Devices trials Research Report on Tobacco Use Cessation Devices

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster - Tobacco Use Disorder/Cigarette Smoking, HIV
Phase 4Not yet recruitingYale University7942027-09-302026-09-23
Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness
Cognitive Behavioral Therapy for Smoking Cessation, Nicotine Replacement Therapy, Bupropion - Tobacco Use Disorder
Not applicableNot yet recruitingVA Office of Research and Development1202027-03-012026-07-20
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use Pharmacotherapy
Text- and web-based support, Nicotine Replacement Therapy (NRT, nicotine patch), Nicotine replacement therapy lozenge - Dual Use of Cigarettes and E-cigarettes
Phase 2Not yet recruitingMedical University of South Carolina3212026-11-012026-10-15
iCanQuit Smoking Cessation Among Hispanic Adults
iCanQuit Smartphone App Smoking Cessation Program, Nicotine Gum, Nicotine Patch - Cigarette Smoking-Related Carcinoma
Phase 3Not yet recruitingFred Hutchinson Cancer Center8542026-10-152026-09-21
Position-Directed Budesonide Nasal Drops for CRS-associated Olfactory Dysfunction
Nasal Drops, Nasal Spray - Chronic Rhinosinusitis (CRS), Olfactory Dysfunction
Not applicableNot yet recruitingPeking University Third Hospital782026-09-252026-09-16
Evaluation of Dependence and Nicotine Replacement Therapy-Supported Cessation Efforts Among Regular Electronic Cigarette Use
Nicotine Replacement Therapies, Brief Behavioral Counseling - E Cigarette Use, Cessation, Tobacco
Phase 4Not yet recruitingWest Virginia University1002026-09-012026-08-26
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
Varenicline (VAR), Nicotine lozenge (NRT), Smartphone intervention with adherence components (COMBO-A) - Smoking Cessation
Phase 2RecruitingUniversity of Oklahoma4962026-07-212026-08-19
My Path to Quit Tobacco
Nicotine patch, Quitline Counseling Phone Calls, Counseling Sessions - Smoking Cessation
Phase 4RecruitingUniversity of Wisconsin, Madison15502026-07-062026-07-23
A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation
Non-invasive vagus nerve stimulator plus nicotine replacement patches, nicotine replacement patches - Smoking Cessation
Phase 2 / Phase 3RecruitingMayo Clinic1502026-06-042026-09-25
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
transdermal nicotine replacement therapy - Smoking
Phase 4RecruitingDuke University6002026-05-062026-07-23
Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients
Auricular acupressure, Nicotine Replacement Therapy (Nicotine patch plus NRT gum or lozenge), Sham Auricular Acupressure - Nicotine Dependence, Nicotine Withdrawal
Not applicableRecruitingChiao-Chiao Liao602026-03-232026-04-13
The Efficacy of Combining Music Intervention With Nicotine Replacement Therapy to Reduce Smoking Craving, Among Healthcare Professionals Who Are Trying to Quit.
Nicotine Replacement Therapy (NRT, nicotine patch), Music intervention, Biological collection - Nicotine Replacement Therapy, Healthcare Professionals
Not applicableNot yet recruitingPoitiers University Hospital802026-03-012026-02-17
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker - Tobacco Dependence
Phase 4Active not recruitingJohns Hopkins University302025-12-102026-07-06
Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Undergoing Thoracic Surgery: A Randomized Controlled Pilot Study
Nicotine patch - Nicotine Dependence, Thoracic Diseases
Not applicableRecruitingHenan Provincial People's Hospital802025-11-302026-01-22
THRIVE in Sedated Gastrointestinal Endoscopy
High-Flow Nasal Oxygen (THRIVE), Standard Nasal Cannula Oxygen - Hypoxemia, Gastrointestinal Endoscopy
CompletedFatih Sultan Mehmet Training and Research Hospital2222025-07-012026-03-23
Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia
Carbon Monoxide Measurement, Nicotine Lozenge, Oral Nicotine Pouch - Cigarette Smoking-Related Carcinoma
Not applicableRecruitingOhio State University Comprehensive Cancer Center10002025-06-132026-06-30
Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Nicotine Replacement Therapy (Nicotine patch plus NRT gum or lozenge), Cytisine, Varenicline (Champix) - Tobacco
Phase 4RecruitingOttawa Heart Institute Research Corporation1502025-04-302026-03-05
Nicotine Patch Plus Nicotine Mouth Spray Versus Nicotine Reduction for Vaping Cessation
Nicotine patches plus nicotine mouth spray, Nicotine Tapering Plan - Vaping Cessation
Phase 3RecruitingUniversity of Auckland, New Zealand7742025-03-252025-04-03
Beta-Adrenergic Modulation of Drug Cue Reactivity
Propranolol, Nicotine Patch, Placebo Propranolol - Tobacco Use Disorder, Nicotine Dependence
Phase 4RecruitingUniversity of Oklahoma802024-11-262026-04-28
C-Raven, a Virtual Tobacco Cessation Intervention in the Community
C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker - Tobacco Dependence
Phase 4CompletedJohns Hopkins University102024-10-302026-02-02

Showing 20 of 396. Sign in to see all of them.

Conditions studied

Smoking Cessation (157)  ·  Tobacco Use Disorder (124)  ·  Smoking (83)  ·  Cigarette Smoking (41)  ·  Tobacco Use Cessation (36)  ·  Schizophrenia (20)  ·  Vaping (20)  ·  Tobacco Smoking (15)  ·  Tobacco Use (15)  ·  Psychotic Disorders (10)  ·  Depression (9)  ·  Acquired Immunodeficiency Syndrome (6)  ·  Harm Reduction (6)  ·  Alcoholism (5)  ·  COVID-19 (5)

Sponsors

Duke University (25)  ·  University of Wisconsin, Madison (17)  ·  M.D. Anderson Cancer Center (14)  ·  National Institute on Drug Abuse (NIDA) (12)  ·  Centre for Addiction and Mental Health (10)  ·  Yale University (10)  ·  Johns Hopkins University (9)  ·  University of California, San Francisco (9)  ·  University of Oklahoma (9)  ·  University of Minnesota (8)  ·  Vanderbilt University Medical Center (8)  ·  H. Lee Moffitt Cancer Center and Research Institute (7)  ·  Mayo Clinic (7)  ·  McNeil AB (7)  ·  The University of Texas Health Science Center, Houston (7)

Countries

United States (284)  ·  Canada (18)  ·  France (13)  ·  Germany (7)  ·  Italy (7)  ·  China (6)  ·  South Africa (4)  ·  Sweden (4)  ·  Austria (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Denmark (2)  ·  Laos (2)  ·  Mexico (2)  ·  Netherlands (2)

Top investigators

Jed E Rose, Ph.D. (9)  ·  Elisabeth Kruse, PhD (6)  ·  Shu-Hong Zhu, Ph.D. (5)  ·  A Eden Evins, MD, MPH (3)  ·  Dorothy Hatsukami, PhD (3)  ·  Jon O Ebbert, MD (3)  ·  Laura MacPherson, PhD (3)  ·  Luba Yammine, PhD (3)  ·  Stephen I Rennard, MD (3)  ·  Vladimir Nekhendzy, MD (3)  ·  Alan S Lewis, MD, PhD (2)  ·  Alejandra Ellison-Barnes, MD (2)  ·  Andrew Pipe, MD (2)  ·  Anton Chau, MD MMSc (2)  ·  Caryn Lerman, Ph.D. (2)

Results publications

PMID 37142273, PMID 37335995, PMID 34611902, PMID 39868569, PMID 37230961, PMID 17874878, PMID 17941858, PMID 20124230, PMID 23669629, PMID 25192771, PMID 25388828, PMID 10191796, PMID 10417762, PMID 10493090, PMID 10510989, PMID 10581887, PMID 10740940, PMID 10748642, PMID 10791509, PMID 10812284, PMID 10885042, PMID 10901493, PMID 11027360, PMID 11176814, PMID 11236847, PMID 11260806, PMID 11516593, PMID 11681767, PMID 11717401, PMID 12010856, PMID 1202204, PMID 12028847, PMID 12047734, PMID 12165190, PMID 12377405, PMID 12438835, PMID 12478880, PMID 12492263, PMID 12509650, PMID 12745503, PMID 12814497, PMID 12832959, PMID 12946238, PMID 13630833, PMID 1453243, PMID 14636967, PMID 15007373, PMID 15010446, PMID 15023708, PMID 1511534

NIH funding

P50DA027840 (8), R01HL109031 (3), 2005 (2), 2008 (2), P50CA084718 (2), P50CA143188 (2), P50DA019706 (2), R01DA038442 (2), R33MH122464 (2), R34DA043751 (2), 1RC1CA144382-01 (1), 2014 (1), K01CA160670 (1), K01DA029645 (1), K02DA034767 (1)